Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.
Caswell-Jin JL, McNamara K, Reiter JG, Sun R, Hu Z, Ma Z, Ding J, Suarez CJ, Tilk S, Raghavendra A, Forte V, Chin SF, Bardwell H, Provenzano E, Caldas C, Lang J, West R, Tripathy D, Press MF, Curtis C.
Caswell-Jin JL, et al. Among authors: forte v.
Nat Commun. 2019 Feb 8;10(1):657. doi: 10.1038/s41467-019-08593-4.
Nat Commun. 2019.
PMID: 30737380
Free PMC article.